Research Analysts Issue Forecasts for Dextera Surgical Inc.’s Q3 2017 Earnings (DXTR)

Dextera Surgical Inc. (NASDAQ:DXTR) – Equities researchers at Wedbush lowered their Q3 2017 earnings per share estimates for shares of Dextera Surgical in a research report issued on Wednesday. Wedbush analyst Levy. T now expects that the brokerage will post earnings per share of ($0.48) for the quarter, down from their previous estimate of ($0.23). Wedbush currently has a “Outperform” rating and a $3.50 target price on the stock. Wedbush also issued estimates for Dextera Surgical’s Q4 2017 earnings at ($0.30) EPS, FY2017 earnings at ($1.59) EPS, FY2018 earnings at ($0.86) EPS and FY2019 earnings at ($0.54) EPS.

Dextera Surgical (NASDAQ:DXTR) last issued its quarterly earnings results on Tuesday, February 7th. The company reported ($0.41) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.34) by $0.07. TRADEMARK VIOLATION WARNING: This story was posted by sleekmoney and is the sole property of of sleekmoney. If you are viewing this story on another domain, it was illegally stolen and republished in violation of U.S. & international trademark & copyright law. The original version of this story can be accessed at http://sleekmoney.com/research-analysts-issue-forecasts-for-dextera-surgical-inc-s-q3-2017-earnings-dxtr/1655729.html.

Separately, Zacks Investment Research raised shares of Dextera Surgical from a “hold” rating to a “buy” rating and set a $1.00 price target for the company in a report on Monday, January 9th.

Shares of Dextera Surgical (NASDAQ:DXTR) opened at 1.17 on Friday. The company’s market cap is $10.45 million. The firm’s 50-day moving average is $1.37 and its 200-day moving average is $1.71. Dextera Surgical has a 12 month low of $0.90 and a 12 month high of $4.30.

TRADEMARK VIOLATION WARNING: This story was posted by sleekmoney and is the sole property of of sleekmoney. If you are viewing this story on another domain, it was illegally stolen and republished in violation of U.S. & international trademark & copyright law. The original version of this story can be accessed at http://sleekmoney.com/research-analysts-issue-forecasts-for-dextera-surgical-inc-s-q3-2017-earnings-dxtr/1655729.html.

About Dextera Surgical

Dextera Surgical Inc, formerly Cardica, Inc, designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons.

5 Day Chart for NASDAQ:DXTR

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/research-analysts-issue-forecasts-for-dextera-surgical-inc-s-q3-2017-earnings-dxtr/1655729.html

Receive News & Ratings for Dextera Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dextera Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *